Medicine for treating respiratory diseases

A respiratory and drug technology, applied in the field of drugs for the treatment of respiratory diseases, can solve the problems of endogenous immunity, collapse of the resistance line of defense, not being fundamentally improved, and difficult to cure.

Active Publication Date: 2013-09-04
张清泉
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the indiscriminate use of antibiotics has not been fundamentally improved so far
Variations of drug-resistant bacteria emerge in endlessly, and newly developed antibiotics and vaccines cannot catch up with the mutation speed of drug-resistant bacteria
The disorder of microbial flora caused by the indiscriminate use of antibiotics and the proliferation of drug-resistant bacteria induced by it, the chronic non-specific inflammatory lesions of the throat and tracheal wall mucosal tissue structure caused by internal environmental pollution, and the collapse of endogenous immunity and resistance defense make respiratory diseases The phenomenon that the diagnosis is easy but the cure is difficult has not been solved

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0010] A medicine for treating respiratory diseases of the present invention, the medicine is an injection, and every 100 milliliters of the injection contains 0.18g-0.22g of sodium aescinate injection, 0.25g-0.35g of adenosine triphosphate disodium, and 0.08 cytochrome C g-0.12g, the balance is aqueous solvent.

[0011] The preferred solution is: the drug is an injection, and every 100 ml of the injection contains 0.2 g of sodium aescinate injection, 0.3 g of adenosine triphosphate disodium, and 0.1 g of cytochrome C, and the balance is an aqueous solvent.

[0012] A further preferred solution is: the medicine is an injection, and 0.3g-0.4g of coenzyme A and 0.1g-0.2g of polymuscular cell injection can be added to the medicine in every 100ml of the injection.

[0013] A kind of medicine for treating respiratory diseases according to the present invention, the medicine is an injection, and the components contained in every 100 milliliters of the injection can have more...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a medicine for treating respiratory diseases. The medicine is injection, and each 100ml of the injection contains 0.18-0.22g of sodium aescinate injection, 0.25-0.35g of disodium adenosine triphosphate, 0.08-0.12g of cytochrome C, and the balance of aqueous solvent. According to the invention, by reducing the permeability of blood capillary, raising the tensity and flow velocity of veins, enhancing peripheral blood circulation and lymph circulation, activating and regulating the bioactivity of the respiratory system, and recovering the microbe ecological balance and endogenous immunity and resistance of probiotics, the purpose of treating respiratory diseases is achieved.

Description

technical field [0001] The invention relates to medicine, which is a medicine for treating respiratory diseases. Background technique [0002] Tracheal and respiratory diseases mainly include asthma, tonsillitis, pharyngitis, bronchitis, etc. The incidence of these diseases is relatively high. At present, western medicine is mainly used for treatment. Most of the western medicine treatment programs must use antibiotics, and these diseases are prone to recurrent attacks Diseases, leading to higher and higher levels of antibiotic use. The harm of antibiotics is ubiquitous. Surveys show that after 5 months of antibiotic use in children, the probability of infection resistance rises to 100%. For patients receiving more than 5 kinds of antibiotics, the concurrent drug toxicity rate is as high as 80%. About 60% of the 10,000 deaf-mute patients are caused by the use of antibiotics when they were young. Therefore, on October 14, 2011, the Ministry of Health issued the most stringe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K38/44A61P11/00A61P11/06A61P11/04A61K31/704A61K31/7076
Inventor 张清泉苏功华潭佳佳
Owner 张清泉
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap